EP2781516
New crystalline forms of the sodium salt of (4- {4- [5- ( 6 - trifluoromethyl - pyridin- 3 - ylamino ) - pyridin- 2 -yl]-phenyl} - cyclohexyl) -acetic acid
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
5.10.2011EP published:
7.12.2016EP application number:
13197714.2
EPO information:
European Patent Register
Max expiry date:
4.10.2031
Title:
New crystalline forms of the sodium salt of (4- {4- [5- ( 6 - trifluoromethyl - pyridin- 3 - ylamino ) - pyridin- 2 -yl]-phenyl} - cyclohexyl) -acetic acid
Timeline
Today
5.10.2011EP application
7.12.2016EP Publication
Owner
Name:
Novartis AGAddress:
Lichtstrasse 35, 4056, Basel, CH
Inventor
Name:
Sutton, Paul, AllenAddress:
East Hanover, NJ New Jersey, US
Name:
Girgis, Michael J.Address:
East Hanover, NJ New Jersey, US
Name:
Liang, JessicaAddress:
East Hanover, NJ New Jersey, US
Name:
Prashad, MahavirAddress:
East Hanover, NJ New Jersey, US
Name:
Villhauer, Edwin, BernardAddress:
East Hanover, NJ New Jersey, US
Priority
Number:
390888 PDate:
7.10.2010Country:
US
Classification
Categories:
C07D 401/12, A61K 31/415, A61P 3/04, C07D 213/72, A61K 31/444, A61K 45/06